Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

ReNeuron gets notice of US cryptopreservation patent

ReNeuron is using cryopreservation technology in its CTX stem cell line
ReNeuron gets notice of US cryptopreservation patent
Ongoing UK clinical trials in both stroke disability and critical limb ischaemia include the technology

ReNeuron (LON:RENE) has received a  Notice of Allowance from the US Patent and Trademark Office for a key patent application covering its cell cryopreservation technology. 

The patent application contains broad claims relating to cryopreserved neural, retinal and mesenchymal stem cells using a formulation developed by ReNeuron that is free of toxic cryopreservants.  

ReNeuron is using cryopreservation technology in its CTX stem cell line to derive a cryopreserved, long shelf life cell therapy candidate, designated CTXcryo.

Ongoing UK clinical trials in both stroke disability and critical limb ischaemia include the technology.  

Olav Hellebø, ReNeuron’s chief executive added the company had invested heavily in patents in recent and the US Notice of Allowance for cell cryopreservation was another important addition.

PhilW.jpg
Why Invest In ReNeuron Group Plc? Read More Here

Register here to be notified of future RENE Company articles
View full RENE profile

ReNeuron Group Plc Timeline

Newswire
February 15 2017
Video
October 28 2016
Article
October 28 2016

Related Articles

5750162705_6312fedf6d_o_opt_58d85af1a1487.jpg
07:00
Find out more from Richard Lipscombe at Proactive's CEO Sessions.
Medical test
August 10 2016
The STOP-HCV-1 clinical trial will assess two direct acting anti-viral (DAA) treatment combinations and whether the addition of another, older drug has value in short course treatment
Blood test
September 27 2016
The group has ambitions to strengthen its transatlantic focus through organic and strategic growth

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use